Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Arca Biopharma Inc (ABIO)

4.27   -0.25 (-5.53%) 03-03 16:39
Open: 4.53 Pre. Close: 4.52
High: 4.58 Low: 4.22
Volume: 972,336 Market Cap: 40M
ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company is headquartered in Westminster, Colorado and currently employs 15 full-time employees. The firm is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The firm's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical trial for the treatment of atrial fibrillation (AF) in patients with heart failure with reduced left ventricular ejection fraction (HFREF). Gencaro is considered part of the beta-blocker class of compounds because of its property of blocking both beta-1 and beta-2, receptors in the heart. The blocking of these receptors prevents the receptor from binding with other molecules, primarily the neurotransmitter norepinephrine (NE), which activate these receptors. The firm is conducting a Phase IIB/III clinical trial of Gencaro, known as GENETIC-AF.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.804 - 4.823 4.823 - 4.844
Low: 4.284 - 4.302 4.302 - 4.323
Close: 4.485 - 4.515 4.515 - 4.55

Technical analysis

as of: 2021-03-03 3:59:39 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.81     One year: 6.42
Support: Support1: 4.12    Support2: 3.43
Resistance: Resistance1: 4.97    Resistance2: 5.50
Pivot: 4.74
Moving Average: MA(5): 4.35     MA(20): 4.74
MA(100): 4.29     MA(250): 4.89
MACD: MACD(12,26): -0.04     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 19.44     %D(3): 16.26
RSI: RSI(14): 42.07
52-week: High: 22.00  Low: 2.21  Change(%): 16.5
Average Vol(K): 3-Month: 97710  10-Days: 164298

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ABIO has closed above bottom band by 15.1%. Bollinger Bands are 83.9% wider than normal. The large width of the bands suggest high volatility as compared to ABIO's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Tue, 02 Mar 2021
Is Arca Biopharma Inc (ABIO) Stock a Good Value? - InvestorsObserver

Fri, 12 Feb 2021
Should You Buy Arca Biopharma Inc (ABIO) Stock After it Has Risen 10.94% in a Week? - InvestorsObserver

Thu, 11 Feb 2021
Arca Biopharma Inc (ABIO) Up 10.16% in Premarket Trading - InvestorsObserver

Mon, 08 Feb 2021
Should You Buy Arca Biopharma Inc (ABIO) Stock? - InvestorsObserver

Wed, 09 Dec 2020
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders - GlobeNewswire

Mon, 02 Nov 2020
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 9
Shares Float (M) 9
% Held by Insiders 0.40
% Held by Institutions 8.43
Shares Short (K) 81
Shares Short P. Month (K) 41

Stock Financials

EPS -2.112
EPS Est This Year -1.750
EPS Est Next Year -1.190
Book Value (p.s.) 5.430
Profit Margin
Operating Margin
Return on Assets (ttm) -11.9
Return on Equity (ttm) -19.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.634
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -4

Stock Valuations

PE Ratio -2.02
PEG Ratio
Price to Book value 0.79
Price to Sales
Price to Cash Flow -6.76

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.